Clinical Trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
A unique approach for cancer treatment including radioactive sources named Alpha DaRT sources: Ra - 224 coated onto stainless steel tubes inserted into the tumor for the treatment of Locally Advanced Pancreatic Cancer .
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-12-31; most recent amendment 2026-06-21.
Status change: Not Yet Recruiting → Recruiting 2026-06-21
Trial Details
NCT Number NCT06755359
Lead Sponsor Alpha Tau Medical LTD.
Conditions Pancreatic Cancer, Locally Advanced Pancreatic Cancer
Enrollment 40 participants
Start Date 2026-03-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-24